天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Cetilistat

Cetilistat ??? ???
?? ??:
282526-98-1
???:
Cetilistat
???(??):
2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one;New alistat;Xitelis;Cetislim;Cetilstat;Cetilista;Sitilista;cetilistat;New ristar;Neo-listat
CBNumber:
CB31012078
???:
C25H39NO3
??? ??:
401.58
MOL ??:
282526-98-1.mol

Cetilistat ??

???
72.0 to 76.0 °C
?? ?
509.7±43.0 °C(Predicted)
??
1.02
?? ??
2-8°C
???
?????(?? ???), ???????(?? ???)
??? ??
??
??? ??
??? ??
?? ?? (pKa)
2.96±0.20(Predicted)
??
???? ?????
InChI
InChI=1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3
InChIKey
MVCQKIKWYUURMU-UHFFFAOYSA-N
SMILES
N1C2=CC=C(C)C=C2C(=O)OC=1OCCCCCCCCCCCCCCCC
CAS ??????
282526-98-1(CAS DataBase Reference)

??

HS ?? 2934.99.4400

Cetilistat C??? ??, ??, ??

??

Cetilistat (also known as ATL-962) was approved in September 2013 by the Japanese Ministry of Health, Labor and Welfare for the treatment of obesity, limited to patients with both type 2 diabetes mellitus (T2DM) and dyslipidemia, and with a body mass index (BMI)25 kg/m2 in spite of dietary treatment and/or exercise therapy. As with orlistat, cetilistat works via inhibition of pancreatic lipases in the gut to inhibit fat absorption and thereby reduce caloric uptake from diet. The medicinal chemistry program has not been described in the scientific literature, but the patent describing cetilistat also describes the synthesis of analogs with varied aryl substituents and lipophilic tails. The synthesis of cetilistat involves condensation of a hexadecylcarbonochloridate with 2-amino-5-methylbenzoic acid; other analogs were synthesized by varying the carbonochloridate and 2-aminobenzoic acid components. Cetilistat is a potent inhibitor of human and rat pancreatic lipase with IC50s of 15 and 136 nM, respectively, with little inhibition of trypsin or chymotrypsin.

??? ??

Off-white Cryst

??

A novel pancreatic lipase inhibitor for the treatment of obesity in both diabetic and non-diabetic patients.

Mechanism of action

Orlistat and cetilistat are both gastrointestinal lipase inhibitors. They effectively inhibit the hydrolysis of dietary fat into fatty acids and monoglyceride in the gastrointestinal tract.52 Orlistat is reported to be able to reduce weight while improving lipid distribution, blood glucose, and blood pressure[1]. Specifically, it isdrugs blocking fat absorption.

Cetilistat ?? ?? ? ???

???

?? ??


Cetilistat ?? ??

???( 434)?? ??
??? ?? ??? ?? ?? ? ??
Wuhan Quanjinci New Material Co.,Ltd.
+86-15271838296; +8615271838296
kyra@quanjinci.com China 1512 58
Shandong Luning Pharmaceutical Co., Ltd.
+86-0546-6491488 +86-13305469775
sale@lntzkg.com China 40 58
Wuhan Haorong Biotechnology Co.,ltd
+86-18565342920; +8618565342920
sales@chembj.net China 289 58
Wuhan Mayue Longteng Technology Development Co., Ltd.
+undefined15171477138
helen.yan@lantu-tech.com China 300 58
Apeloa production Co.,Limited
+8619933239880
admin@apcl.com.cn China 852 58
Shandong Hanjiang Chemical Co., Ltd
+86-0533-2066820 +8618369939125
hanson@sdhanjiang.com China 998 58
Shanghai Likang New Materials Co., Limited
+86-16631818819 +86-17736933208
3684455296@qq.com China 9300 58
Hebei Weibang Biotechnology Co., Ltd
+8615531157085
abby@weibangbio.com China 8810 58
Hebei Yanxi Chemical Co., Ltd.
+8617531190177
peter@yan-xi.com China 5857 58
XI'AN TIANGUANGYUAN BIOTECH CO., LTD.
+86-029-86333380 18829239519
sales06@tgybio.com China 901 58

Copyright 2019 ? ChemicalBook. All rights reserved